Epigenetic Long-Term X-Repressor - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Wall Street welcomes Repligen’s $1.5bn BioLife deal, but integration now matters

Popular’s CEO is retiring after 14 months. Why investors should watch the CFO taking over

Renishaw plc (LSE: RSW) beats upgraded guidance with £815m full-year revenue

China targets 14 European entities as Russia sanctions trigger new EU trade confrontation

Read More

Pharma Industry News

Scribe Therapeutics unveils ELXR technology breakthrough at Keystone Symposia 2025

Scribe Therapeutics has presented new data on its Epigenetic Long-Term X-Repressor (ELXR) technology at the 2025 Keystone Symposia…

byPallavi Madhiraju

March 7, 2025

web analytics